Pretreatment Alkaline Phosphatase and Epstein-Barr Virus DNA Predict Poor Prognosis and Response to Salvage Radiotherapy in Patients with Nasopharyngeal Carcinoma and Metachronous Bone-Only Metastasis
Open Access
- 1 January 2017
- journal article
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 8 (3) , 417-424
Abstract
Background: The bones are the most common site of distant metastasis in nasopharyngeal carcinoma (NPC). Few prognostic markers are available to guide treatment and sub-classify patients with bone metastasis. We aimed to identify the prognostic value of pretreatment serum alkaline phosphatase (ALP) and plasma Epstein-Barr virus DNA (EBV DNA) in patients with bone-only metastasis.Keywords
This publication has 28 references indexed in Scilit:
- Prognostic Impact of Plasma Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Treated using Intensity-Modulated Radiation TherapyScientific Reports, 2016
- Mortality Characteristic and Prediction of Nasopharyngeal Carcinoma in China from 1991 to 2013Asian Pacific Journal of Cancer Prevention, 2015
- Distant metastasis risk and patterns of nasopharyngeal carcinoma in the era of IMRT: long-term results and benefits of chemotherapyOncotarget, 2015
- A Comparison between the Sixth and Seventh Editions of the UICC/AJCC Staging System for Nasopharyngeal Carcinoma in a Chinese CohortPLOS ONE, 2014
- Alkaline Phosphatase: An OverviewIndian Journal of Clinical Biochemistry, 2013
- Nasopharyngeal carcinoma: The next challengesEuropean Journal of Cancer, 2010
- Evaluation of bone and mineral disorders.2007
- Comparison of Epstein-Barr virus DNA level in plasma, peripheral blood cell and tumor tissue in nasopharyngeal carcinoma.2005
- In-depth evaluation of the AJCC/UICC 1997 staging system of nasopharyngeal carcinoma: Prognostic homogeneity and proposed refinementsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2003
- Combined Chemoradiation Versus Radiation Therapy Alone in Locally Advanced Nasopharyngeal CarcinomaAmerican Journal of Clinical Oncology, 2002